Frasers Property Set to Be the First Mall Operator in Singapore to Roll Out UV-Disinfecting Mobile Robots in Collaboration with PBA Group
The Sunburst UV Bots to debut in Northpoint City this May SINGAPORE - Media OutReach - 23 Apr 2020…
6 years ago
Solomon Systech always stands by you under COVID-19
HONG KONG, CHINA - Media OutReach - 23 April 2020 - The ongoing situation of COVID-19, inevitably, affects our families,…
6 years ago
Olympus Launches EVIS X1, its Most Advanced Endoscopy System to Date
Elevating the standard of endoscopy HAMBURG, Germany & TOKYO, Japan--(BUSINESS WIRE)--Olympus Corporation (President: Yasuo Takeuchi)…
6 years ago
China to Overtake the United States as the Most Resilient IPO Market in 2020
LONDON--(BUSINESS WIRE)--#IPO--Global market research company Euromonitor International launched an IPO Market Resilience Index identifying the…
6 years ago
CMIC Group Supports Clinical Trials and Manufacturing of Influenza Antiviral Drug “Avigan® Tablet” and Contributes to Accelerating Provision for COVID-19 Patients
TOKYO--(BUSINESS WIRE)--#Avigan--CMIC HOLDINGS Co., Ltd. (Head Office: Tokyo, Minato-ku, Representative Director & CEO Kazuo Nakamura,…
6 years ago
Drawbar Springs with Inbuilt Safety Feature Now Available from Lee Spring
Drawbar springs with an inbuilt safety feature now available from Lee Spring are of value…
6 years ago
Jennifer Juan joins Alphabet Radio, with New LGBTQUIA+ Poetry Show, Diverse Verse
Writer and musician Jennifer Juan has joined LGBTQUIA+ pop up radio station, Alphabet Radio, as…
6 years ago
COVID-19 Update: Highly Potent Active Pharmaceutical Ingredients 2020 Now Remote Access only
SMi Reports: The upcoming Highly Potent Active Pharmaceutical Ingredients conference is now via remote access…
6 years ago
ViSenze Improves Product Discovery With Deep Visual Attribution
By expanding its product taxonomy to cover over 70 fashion product categories and adding 225…
6 years ago
EpimAb Biotherapeutics and QIMR Berghofer Medical Research Institute Announce Research Collaboration and License Agreement on Novel Bispecific Target Combinations
EpimAb receives exclusive access to newly discovered target combinations in order to expand its proprietary…
6 years ago